Findings Across the Literature

Controlled ozone exposure produces measurable oxidative and physiological effects. It generates a mild oxidative challenge that activates antioxidant defenses, enhances micro-circulation, improves oxygen release from hemoglobin, and influences inflammatory signaling. Laboratory and pre-clinical studies show that ozone can induce apoptosis, suppress cell migration, reduce tumor burden in animals, and increase sensitivity of certain cancers to radiation or chemotherapy through pathways involving reactive oxygen species, AMPK, SR-A, and HIF-1α modulation.

In reproductive medicine, ozone sauna combined with pulsed electromagnetic field therapy increased embryo counts and endometrial thickness among women with diminished ovarian reserve. In oncology research, in-vitro ozone exposure to MDA-MB-231 breast-cancer cells decreased viability and migration while increasing apoptotic activity. A mouse model of esophageal cancer demonstrated smaller tumors and reduced inflammatory markers when ozone was paired with radiation. An ozone-loaded lipid gel delivering doxorubicin locally suppressed primary and metastatic tumor growth in animals, showing synergy with radiotherapy through oxidative mechanisms.

Comprehensive reviews on breast cancer and high-grade glioma summarize similar biochemical findings—improved oxygenation and oxidative-signaling modulation—but acknowledge that human clinical data remain limited. An evidence-and-gap map documents research in pain, infection, inflammation, and wound healing, identifying the same need for standardized methodology. A correspondence article explicitly states that ozone therapy is not suitable as a primary cancer treatment.

Overall, the collected papers present consistent laboratory evidence of ozone’s oxidative activity and potential adjunctive influence on conventional therapies, accompanied by authors’ repeated emphasis on the need for rigorous, controlled human studies and clear clinical protocols.